Twenty eight people developed blood clots with low platelets after receiving
The 28 cases were identified out of 8.7 million doses of J&J’s vaccine administered in the U.S., the CDC said in a presentation posted online Wednesday ahead of a meeting of the agency’s immunization advisory committee. The panel will review the new data on the condition, called thrombosis with thrombocytopenia syndrome.
U.S. health agencies paused use of J&J’s vaccine for 10 days last month while they investigated the rare and potentially fatal side ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.